U.S. Stock News

If you are looking at Bitdeer Technologies Group and wondering whether the recent share price reflects a fair value, you are not alone. The stock last closed at US$7.78, after share price returns of a 22.8% decline over 7 days, a 46.5% decline over 30 days and a 32.6% decline year to date, with a 40.6% decline over the past year and a 26.9% decline over three years. Recent news coverage has focused on Bitdeer Technologies Group as a listed player in the broader software and crypto...

Avery Dennison Corporation recently reported Q4 results showing 3.9% year-on-year revenue growth, a slight revenue miss versus estimates, and EPS guidance that came in modestly ahead of analyst expectations, while maintaining a 16.4% adjusted EBITDA margin and generating over US$700.00 million in adjusted free cash flow. These results highlight how the company’s ability to sustain margins and strong cash generation, despite tariff pressures and softer consumer volumes, is becoming an...

Recent performance snapshot MKS (MKSI) has drawn investor interest after a recent move that leaves the shares about 19% higher over the past month and roughly 73% higher in the past 3 months, based on the latest available returns. See our latest analysis for MKS. Set against a 1 year total shareholder return of 153.62% and a 3 year total shareholder return of 189.93%, the recent 19.45% 1 month share price return suggests momentum has been strong, even with a softer 7 day share price move. If...

In February 2026, Eastman Chemical Company completed a US$598.72 million fixed-rate senior unsecured notes offering due 2031, while its board affirmed a quarterly cash dividend of US$0.84 per share payable in April and confirmed completion of a multi-year US$3,155.42 million share repurchase program initiated in 2018. The company’s ability to fund itself through the bond market, maintain a long-running dividend stream, and finish a sizeable buyback highlights how its capital allocation...

Inter & Co, Inc. has already reported its full-year 2025 results, with net interest income rising to BRL 6.27 billion and net income to BRL 1.31 billion, and the board approved a cash dividend of US$0.113101823 per common share for shareholders of record as of February 22, 2026. For Brazilian Depositary Receipt holders, the company estimated a gross dividend of BRL 0.594689388 per BDR based on a BRL 5.2580 PTAX rate, underscoring how its U.S.-listed cash payout translates into local-currency...

GlobalFoundries Inc. recently reported fourth-quarter 2025 sales of US$1,830 million with net income of US$199 million, announced a new share repurchase program of up to US$500 million over 12 months, and confirmed that President and COO Niels Anderskouv will resign in March 2026. At the same time, GlobalFoundries and Renesas Electronics Corporation entered a multi‑billion‑dollar partnership aimed at securing long‑term chip supply for automotive and industrial customers using...

iRhythm Holdings (IRTC) caught investor attention after reporting record fourth quarter revenue and its first positive quarterly net income, supported by Zio service demand and fresh 2026 guidance pointing to volume driven growth. See our latest analysis for iRhythm Holdings. Even with the latest earnings headlines, the share price has been under pressure recently, with a 7 day share price return of 4.68% set against a 90 day share price return decline of 17.60% and a 1 year total shareholder...

Why OSI Systems is in focus today OSI Systems (OSIS) is back on investors' radar after its Security division reported that the Itemiser 4DX and new Itemiser 5X trace detection systems received ECAC/EU G1 approval, meeting stringent European aviation security standards. This certification confirms compliance with European Civil Aviation Conference and European Commission requirements, and ties directly to how the company competes in global aviation security and broader high security screening...

Grand Canyon Education, Inc. has reported its fourth-quarter and full-year 2025 results, showing higher quarterly net income of US$86.73 million and earnings per share growth, alongside issuing detailed 2026 guidance that outlines expected service revenue, operating margins and diluted EPS across each quarter and for the full year. At the same time, the company expanded its stock repurchase authorization to a very large US$2.55 billion program running through March 2027 and elevated...

In February 2026, Federal Realty Investment Trust reported past fourth-quarter and full-year 2025 results showing higher revenue and net income year over year, issued 2026 net income guidance of US$3.90–US$4.00 per diluted share, and its Board declared regular quarterly common and preferred cash dividends payable on April 15, 2026. An interesting wrinkle is that, despite having an authorized buyback in place, Federal Realty did not repurchase any shares in the fourth quarter of 2025,...

Why Dominion Energy’s earnings report is in focus Dominion Energy (D) heads into its February 23, 2026 earnings release with investors watching how the expected $0.66 EPS and revenue figures line up against recently reduced analyst expectations and earlier cautious trading. See our latest analysis for Dominion Energy. Dominion Energy’s recent moves capture that tension, with a 10.67% 1 month share price return and 7.08% 3 month share price return contrasting with a stronger 20.32% 1 year...

Kadant Inc. reported past fourth-quarter 2025 sales of US$286.2 million, up from US$258.03 million a year earlier, with essentially flat quarterly earnings per share, while full-year 2025 sales held around US$1.05 billion and net income and EPS eased compared with the prior year. The company coupled these results with 2026 guidance that points to higher revenue and GAAP EPS and stands to benefit from the recent Supreme Court decision striking down certain tariffs, which may reduce input...

In February 2026, Allstate reported estimated January catastrophe losses of US$175 million tied mainly to Winter Storm Fern and confirmed plans for a US$4.00 billion share repurchase alongside an 8% increase in its common dividend. On the capital side, the company also declared about US$29.30 million in cash dividends on three preferred stock series, underscoring continued commitments to both common and preferred shareholders despite recent weather-related losses. With this backdrop of...

Earlier this week, Merit Medical Systems announced it will report quarterly earnings after Tuesday’s market close, following a prior quarter in which it exceeded analyst revenue expectations and delivered strong organic growth. This combination of an upcoming results release and evidence of recent operational momentum has sharpened investor focus on how effectively Merit is using its capital base despite scale disadvantages and a modest return on invested capital. Next, we’ll examine how the...

IQVIA Holdings (IQV) is back in focus after closing 2025 with revenue and EPS growth near double digits, record R&D Solutions net bookings, and a new obesity research collaboration with Duke Clinical Research Institute. See our latest analysis for IQVIA Holdings. Despite the recent obesity research collaboration and solid year-end results, IQVIA Holdings’ share price has come under pressure, with a 30 day share price return of 29.62% and a 1 year total shareholder return of 13.31%. This...

Earlier this month, Tempus AI launched its new HRD-RNA algorithm for research use, an AI-driven 1,660-gene model designed to better identify homologous recombination deficiency and potential responders to platinum chemotherapy or PARP inhibitors across solid tumors, with clinical availability planned later in 2026. The RNA-based, functional approach may widen the pool of patients who can be matched to targeted therapies compared with traditional DNA “genomic scar” tests, while Tempus also...

Becton Dickinson (BDX) shares are back in focus after the company reported first quarter earnings and reaffirmed its full year 2026 guidance, as well as launching a US$1.6b tender offer for outstanding debt securities. See our latest analysis for Becton Dickinson. At a share price of US$185.39, Becton Dickinson has seen near term momentum pick up, with a 1 day share price return of 1.6% and 7 day share price return of 5.4%, following earnings, buyback activity and the US$1.6b debt tender. Its...

In February 2026, Calix, Inc. announced that Helexon selected its Calix One platform for a multi-year, BEAD-funded rural broadband fiber buildout across Illinois, Indiana, Kentucky, and Michigan, while also rolling out new AI-native platform enhancements and SmartHome features like HomeOfficeIQ and an upgraded Engagement Cloud. Together, these moves show Calix pushing deeper into experience-focused, AI-enabled broadband solutions that can help providers personalize services, streamline...

In February 2026, First Solar, Inc. entered into a new five-year senior unsecured revolving credit facility of US$1.50 billion, replacing its prior secured facility and releasing associated collateral to support working capital and general corporate purposes. The shift from secured to unsecured bank financing signals increased financial flexibility and confidence from lenders, potentially broadening First Solar’s options for funding expansion and managing trade-related cost pressures. With...

If you are wondering whether Moderna's current share price still reflects its long term potential, you are not alone. This article focuses squarely on what the stock might be worth based on different valuation lenses. Moderna's share price closed at US$49.87, with returns of 18.1% over the last 7 days, 2.4% over 30 days and 61.6% year to date, while the 1 year return is 40.4% and the 3 and 5 year returns are negative at 64.2% and 67.8% respectively. Recent headlines have continued to focus...

Aehr Test Systems previously announced that it received a firm production order from a world-leading hyperscaler to test high-performance AI accelerator chips, with the contract expected to meaningfully influence its revenue and earnings as early as the second quarter of 2026. This deal highlights Aehr’s role as a key enabling partner in the complex testing demands of next-generation AI data center infrastructure. Next, we’ll examine how this hyperscaler AI chip-testing contract shapes Aehr...

Why Blue Bird (BLBD) is on investors’ radar now Blue Bird (BLBD) has drawn fresh attention after recent share price moves that leave it trading around $61. This has prompted investors to reassess the school bus manufacturer’s value, growth profile, and risk-reward trade off. See our latest analysis for Blue Bird. Recent moves to around $61 come after a 23.06% 1 month share price return and a 30.45% year to date share price return, alongside a 73.89% 1 year total shareholder return. This...

On February 15, 2026, AtaiBeckley Inc. announced that experienced biopharma finance executive Michael Faerm will become Chief Financial Officer and principal financial officer on March 9, 2026, while current CFO Anne Johnson will shift to Chief Accounting Officer and remain principal accounting officer. This leadership reshuffle pairs Faerm’s capital-markets and operating background with Johnson’s continuity in accounting oversight, potentially sharpening AtaiBeckley’s financial execution as...

Dyne Therapeutics (DYN) is back in focus after highlighting five upcoming presentations at the 2026 Muscular Dystrophy Association conference and securing Orphan Drug designation in Japan for its myotonic dystrophy type 1 therapy. See our latest analysis for Dyne Therapeutics. Despite the recent regulatory and conference catalysts, Dyne Therapeutics’ short term momentum has cooled, with a 30 day share price return decline of 17.33% and a 90 day decline of 31.33%, even as the 1 year total...